hero

Client:
Novartis
Share:

Relaunching a brand

Tykerb, the HER2-targeted agent for metastatic breast cancer (MBC), had very low awareness among patients even though it had been on the market for more than 7 years. GTO changed all that with a new DTC campaign that re-launched the brand to women living with HER2+ MBC